ANN ARBOR, Mich., Oct. 28 /PRNewswire-FirstCall/ -- Adeona
Pharmaceuticals, Inc., (AMEX: AEN) announced today that the Company
will hold its Annual Shareholders Meeting on Tuesday, November 2, from 9 a.m. to 10 a.m., at its offices located at 3930
Varsity Drive, Ann Arbor, MI,
48108.
During the Annual Shareholder Meeting, Adeona's Chief Executive
Officer, James S. Kuo, M.D., M.B.A.,
will give an update on the Company's activities and answer
questions. Admission is open to any Adeona shareholder of record as
of September 23, 2010.
About Adeona Pharmaceuticals, Inc.
Adeona (AMEX: AEN) is a pharmaceutical company developing new
medicines for serious central nervous systems diseases. Our primary
strategy is to license clinical-stage drug candidates that have
already demonstrated a certain level of clinical efficacy and
develop them to a valuation inflection point resulting in a
significant development and marketing collaboration. We have four
drug candidates and one medical food candidate in development.
Further information on the company is available at
www.adeonapharma.com.
SOURCE Adeona Pharmaceuticals, Inc.
Copyright . 28 PR Newswire